BAILII
British and Irish Legal Information Institute


Freely Available British and Irish Public Legal Information

[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback]

United Kingdom Intellectual Property Office Decisions


You are here: BAILII >> Databases >> United Kingdom Intellectual Property Office Decisions >> RENERVEX (Trade Mark: Opposition) [2000] UKIntelP o04700 (16 February 2000)
URL: http://www.bailii.org/uk/cases/UKIntelP/2000/o04700.html
Cite as: [2000] UKIntelP o4700, [2000] UKIntelP o04700

[New search] [Printable PDF version] [Help]

RENERVEX (Trade Mark: Opposition) [2000] UKIntelP o04700 (16 February 2000)

For the whole decision click here: o04700

Trade mark decision

BL Number
O/047/00
Decision date
16 February 2000
Hearing officer
Dr W J Trott
Mark
RENERVEX
Classes
05
Applicants
Amgen Inc
Opponents
Bristol-Myers Squibb Company
Opposition
Sections 5(2)(b) & 5(4)(a)

Result

Section 5(2)(b) - Opposition failed

Section 5(4)(a) - Opposition failed

Points Of Interest

  • 1. "The law requires ‘a likelihood of confusion’. A mere possibility of confusion (in exceptional circumstance) is not enough."

Summary

The opposition was based on the opponents’ earlier mark PRESERVEX, in Class 5. The Hearing Officer concluded that the marks were not sufficiently similar as to give rise to a likelihood of confusion. The possibility that the marks might be poorly reproduced, in use, could not form part of the Hearing Officer’s considerations, he found. The evidence of use did not support the case under passing off.


About BAILII - FAQ - Copyright Policy - Disclaimers - Privacy Policy amended on 25/11/2010